Stay updated with breaking news from Note Conversion Agreement. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
KANSAS CITY, Kan., Jan. 29, 2024 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING) (Cingulate), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform technology to build
Akanda Corp. Unaudited Condensed Interim Consolidated Statements of Financial Position As at ...
Insider warrant exercise and new credit facility improve balance sheet ...
Conversion of significant debt to equity and extension of short-term note delivers significantly improved debt position for the company as it looks forward to the year ahead ...